Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Expert Opinion on Biological Therapy|June 17, 2009
Reovirus-based therapy for cancerKevin Kelly, Steffan Nawrocki, Alain Mita, et al.Cancer Chemotherapy and Pharmacology|May 11, 2004
In vitro assessment of nucleoside analogs in multiple myelomaNancy L Krett, Mary Ayres, Chadi Nabhan, et al.Investigational New Drugs|February 18, 2011
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxelMichael Millward, Paul Mainwaring, Alain Mita, et al.Cancer Biology & Therapy|October 13, 2004
Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenograftsChandrajit P Raut, Steffan Nawrocki, Laura M Lashinger, et al.Biomedical Reports|April 12, 2019
Plinabulin, an inhibitor of tubulin polymerization, targets KRAS signaling through disruption of endosomal recyclingPatrick J Cimino, Lan Huang, Lihua Du, et al.Clinical Lymphoma, Myeloma & Leukemia|May 1, 2019
Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple MyelomaFaiz Anwer, Kevin Mathew Gee, Ahmad Iftikhar, et al.Pageof 1